URATE LOWERING EFFECT OF FEBUXOSTAT AMONG PATIENTS WITH ASYMPTOMATIC HYPERURICEMIA IN ADVANCED CHRONIC KIDNEY DISEASE: A CASE-SERIES

被引：0
|
作者：
Erika Bianca, Villazor-Isidro [1 ]
Christine Joy, Pega-Flores [1 ]
John Carlo, Brojan [1 ]
Paul, Santos-Estrella [2 ]
Jeanne, Bayaca [3 ]
机构：
[1] St Lukes Med Ctr, Dept Med, Quezon City, Philippines
[2] St Lukes Med Ctr, Rheumatol Sect, Quezon City, Philippines
[3] St Lukes Med Ctr, Nephrol Sect, Quezon City, Philippines
来源：
NEPHROLOGY | 2014年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
  • [21] The Efficacy and Safety of Febuxostat for Hyperuricemia in Hypertensive Patients with Chronic Heart Failure and Chronic Kidney Disease
    Naka, Toshio
    Andou, Tomotaka
    Masuyama, Tohru
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S194 - S194
  • [22] A formula predicting the effective dose of febuxostat in chronic kidney disease patients with asymptomatic hyperuricemia based on a retrospective study and a validation cohort
    Aoun, Mabel
    Salloum, Rayane
    Dfouni, Antoine
    Sleilaty, Ghassan
    Chelala, Dania
    CLINICAL NEPHROLOGY, 2020, 94 (02) : 61 - 69
  • [23] Urate-lowering efficacy and renal safety of febuxostat in patients with hyperuricemia and stage 4-5 chronic kidney disease not yet on dialysis: A meta-analysis of observational studies
    Jeong, Hye-Jin
    Park, Woo Yeong
    Kim, Sang-Hyon
    Dalbeth, Nicola
    Son, Chang-Nam
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 56
  • [24] To Compare the Efficacy of Febuxostat Versus Allopurinol in patients with Hyperuricemia due to Chronic Kidney Disease
    Elahi, Wajeeha
    Syed, Ameen Zubair
    Das, Bhagwan
    Dayo, Bella
    Memon, Rafia
    Naz, Afreen
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (04): : 942 - 944
  • [25] RENOPROTECTIVE EFFECT OF URATE LOWERING THERAPY IN GOUTY PATIENTS WITH STAGE 3 CHRONIC KIDNEY DISEASE
    Calvo, E.
    Novella-Navarro, M.
    Aramburu, F.
    Janta, I.
    Cabrera-Alarcon, J. L.
    Sala, L.
    Prada, A.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S452 - S452
  • [26] Febuxostat was Better than Allopurinol in Patients with Advanced Chronic Kidney Disease
    Hao, Zhen-Ye
    Qiao, Peng-Yan
    Wei, James Cheng-Chung
    Zhang, Li-Yun
    AMERICAN JOURNAL OF MEDICINE, 2025, 138 (04): : e68 - e68
  • [27] Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy
    Lee, Tao Han
    Chen, Jia-Jin
    Wu, Chao-Yi
    Yang, Chih-Wei
    Yang, Huang-Yu
    DIAGNOSTICS, 2021, 11 (09)
  • [28] Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Chang, Chia-Ling
    Yang, Chen-Chang
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (12): : 2599 - 2606
  • [29] Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study
    Haibo Yu
    Xinying Liu
    Yaxiang Song
    Jiafen Cheng
    Hui Bao
    Ling Qin
    Xuan Zhou
    Ling Wang
    Ai Peng
    Clinical and Experimental Nephrology, 2018, 22 : 1324 - 1330
  • [30] RENOPROTECTIVE EFFECTS OF FEBUXOSTAT AND ALLOPURINOL IN PATIENTS WITH HYPERURICEMIA AND CHRONIC KIDNEY DISEASE: A META-ANALYSIS
    Edding, Sherida
    Cabral, Brian Michael
    Cating-Cabral, Monica Therese
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 565 - 565
12345